全球心包膜穿刺術市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

心包穿刺市場預計將從 2025 年的 13.1 億美元成長到 2034 年的 21.9 億美元，2026 年至 2034 年的複合年成長率為 5.87%。

由於需要緊急排放心包膜腔積液的心血管併發症不斷增加，全球心包膜穿刺術市場正穩定成長。心包膜穿刺術是一種用於清除心臟周圍積液、緩解壓力並恢復正常心臟功能的醫療程序。人們對先進心臟護理的認知不斷提高以及醫院急診醫療服務的改善，正推動著該手術在臨床實踐中的應用日益廣泛。

推動市場成長的因素有很多，包括心臟病、感染疾病和癌症相關的心包儲存率不斷上升。醫院和心臟中心擴大採用先進的影像技術，例如心臟超音波圖和超音波引導，以提高手術的安全性和準確性。醫療基礎設施的擴建和對心血管護理投入的增加也推動了心包穿刺術專用設備的應用。

隨著醫療技術的不斷進步，心臟治療效果持續提升，市場前景依然樂觀。微創器械的研發和導管設計的改進有望提高手術效率和病人安全性。新興市場心臟護理服務的拓展將為醫療服務提供者創造更多機會。隨著全球心血管疾病發生率的持續上升，對心包膜穿刺術等高效急救手術的需求預計將會增加。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球心包膜穿刺市場：依手術類型分類

• 市場分析、洞察與預測
• 緊急心包穿刺術
• 選擇性心包膜穿刺術

第5章：全球心包穿刺技術市場：依引導法分類

• 市場分析、洞察與預測
• 超音波心動圖引導
• 在透視下
• CT引導

第6章：全球心包膜穿刺技術市場：依應用領域分類

• 市場分析、洞察與預測
• 心臟壓塞
• 心膜炎
• 心包膜儲存

第7章：全球心包穿刺技術市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 專科診所

第8章 全球心包穿刺市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Siemens Healthineers
  • Baxter International
  • Roche
  • GE Healthcare
  • Johnson And Johnson
  • Medtronic
  • Boston Scientific
  • Hologic
  • Terumo Corporation
  • Philips Healthcare
  • Cpachealth
  • Abbott Laboratories
  • Braun Melsungen
  • Stryker
  • Cardinal Health

The Pericardiocentesis Procedures Market size is expected to reach USD 2.19 Billion in 2034 from USD 1.31 Billion (2025) growing at a CAGR of 5.87% during 2026-2034.

The global pericardiocentesis procedures market has grown steadily due to increasing cases of cardiovascular complications that require emergency fluid drainage from the pericardial sac. Pericardiocentesis is a medical procedure used to remove excess fluid around the heart, helping relieve pressure and restore normal cardiac function. Rising awareness about advanced cardiac care and improvements in hospital emergency services have contributed to the increased use of this procedure in clinical settings.

Several factors are driving market growth, including the rising prevalence of heart diseases, infections, and cancer-related pericardial effusions. Hospitals and cardiac centers are increasingly adopting advanced imaging technologies such as echocardiography and ultrasound guidance to improve procedural safety and accuracy. Growing healthcare infrastructure and increasing investments in cardiovascular care are also encouraging the adoption of specialized equipment used during pericardiocentesis procedures.

The future outlook for the market remains promising as medical technologies continue to enhance cardiac treatment outcomes. The development of minimally invasive tools and improved catheter designs may increase procedural efficiency and patient safety. Expanding cardiac care services in emerging economies will likely create additional opportunities for healthcare providers. As cardiovascular disease rates continue to rise globally, demand for effective emergency procedures such as pericardiocentesis is expected to grow.

MARKET SEGMENTATION

By Procedure Type

• Emergency Pericardiocentesis
• Elective Pericardiocentesis

By Guidance Method

• Echocardiography-Guided
• Fluoroscopy-Guided
• CT-Guided

By Application

• Cardiac Tamponade
• Pericarditis
• Pericardial Effusion

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

COMPANIES PROFILED

• Siemens Healthineers, Baxter International, Roche, GE Healthcare, Johnson and Johnson, Medtronic, Boston Scientific, Hologic, Terumo Corporation, Philips Healthcare, Cpachealth, Abbott Laboratories, Braun Melsungen, Stryker, Cardinal Health
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Procedure Type
• 4.2. Emergency Pericardiocentesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Elective Pericardiocentesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY GUIDANCE METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Guidance Method
• 5.2. Echocardiography-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Fluoroscopy-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. CT-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiac Tamponade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pericarditis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pericardial Effusion Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Procedure Type
  • 8.2.2 By Guidance Method
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Procedure Type
  • 8.3.2 By Guidance Method
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Procedure Type
  • 8.4.2 By Guidance Method
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Procedure Type
  • 8.5.2 By Guidance Method
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Procedure Type
  • 8.6.2 By Guidance Method
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PERICARDIOCENTESIS PROCEDURES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Siemens Healthineers
  • 10.2.2 Baxter International
  • 10.2.3 Roche
  • 10.2.4 GE Healthcare
  • 10.2.5 Johnson And Johnson
  • 10.2.6 Medtronic
  • 10.2.7 Boston Scientific
  • 10.2.8 Hologic
  • 10.2.9 Terumo Corporation
  • 10.2.10 Philips Healthcare
  • 10.2.11 Cpachealth
  • 10.2.12 Abbott Laboratories
  • 10.2.13 Braun Melsungen
  • 10.2.14 Stryker
  • 10.2.15 Cardinal Health